Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest update is out from Byline Bancorp ( (BY) ).
On June 12, 2025, the Estate of Daniel L. Goodwin and Equity Shares Investors, LLC completed the sale of 4,282,210 shares of Byline Bancorp, Inc. common stock in a registered public offering. Byline Bancorp did not receive proceeds from this sale but repurchased 418,235 shares at $23.91 each under its stock repurchase program, with some directors purchasing shares worth $1.27 million, indicating strategic financial maneuvers and stakeholder involvement.
The most recent analyst rating on (BY) stock is a Hold with a $33.00 price target. To see the full list of analyst forecasts on Byline Bancorp stock, see the BY Stock Forecast page.
Spark’s Take on BY Stock
According to Spark, TipRanks’ AI Analyst, BY is a Outperform.
Byline Bancorp demonstrates solid financial performance with consistent revenue growth and improved leverage ratios, complemented by a favorable valuation. The recent earnings call highlighted strong financial results and successful strategic initiatives, although challenges like economic uncertainty and pressures on specific business segments remain. Technical indicators suggest a mixed trend, with potential for recovery. Overall, the stock presents a stable investment opportunity with promising growth prospects.
To see Spark’s full report on BY stock, click here.
More about Byline Bancorp
Byline Bancorp, Inc. operates in the financial services industry, focusing on providing banking products and services. The company is known for its market presence in offering a range of financial solutions to its clients.
Average Trading Volume: 185,940
Technical Sentiment Signal: Buy
Current Market Cap: $1.23B
See more data about BY stock on TipRanks’ Stock Analysis page.